Navigating Asia–EMA Regulatory Pathways to Accelerate Global Development

• Compare regulatory frameworks, approval pathways, and clinical trial requirements across key Asian markets and the EMA
• Identify opportunities to streamline global development by leveraging Asia’s evolving regulatory landscape
• Highlight emerging opportunities for biotechs to expand into Asian markets through collaborative or parallel regulatory approaches

Speakers:

Anna Litsiou

Director Regulatory Policy & Intelligence

AstraZeneca